Education
About Us
Working with TipRanks
Follow Us
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
Kymera Therapeutics (KYMR) Ownership Overview
11.73% Insiders
31.69% Mutual Funds
17.44% Other Institutional Investors
12.89% ETFs
26.25% Public Companies and
Individual Investors
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 62.01% of the company’s stock is owned by Institutional Investors, 11.73% is owned by Insiders, and 26.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 01, 2025 | xxxxxxxxxxxxx | $13955348 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $28842000 | |
Mar 03, 2025 | xxxxxxxxxxxxx | $174747 | |
Mar 03, 2025 | xxxxxxxxxxxxx | $214172 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,651,429 | Institution | 9.24% | 423,230,427 | |
| 6,117,295 | Insider | 8.50% | 389,243,481 | |
| 4,949,446 | Institution | 6.88% | 314,933,249 | |
| 4,939,643 | Institution | 6.87% | 314,309,484 | |
| 2,901,399 | Institution | 4.03% | 184,616,018 | |
| 2,556,999 | Institution | 3.55% | 162,701,846 | |
| 2,387,009 | Institution | 3.32% | 151,885,383 | |
| 2,301,791 | Institution | 3.20% | 146,462,961 | |
| 1,366,008 | Institution | 1.90% | 86,919,089 | |
| 1,112,387 | Institution | 1.55% | 70,781,185 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,949,446 | Institution | 6.88% | 314,933,249 | |
| 2,901,399 | Institution | 4.03% | 184,616,018 | |
| 2,556,999 | Institution | 3.55% | 162,701,846 | |
| 2,387,009 | Institution | 3.32% | 151,885,383 | |
| 1,366,008 | Institution | 1.90% | 86,919,089 | |
| 1,112,387 | Institution | 1.55% | 70,781,185 | |
| 977,897 | Institution | 1.36% | 62,223,586 | |
| 600,500 | Institution | 0.83% | 38,209,815 | |
| 562,990 | Institution | 0.78% | 35,823,054 | |
| 550,800 | Institution | 0.77% | 35,047,404 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,780,512 | Institution | 2.47% | 100,776,979 | |
| 1,355,414 | Institution | 1.88% | 76,716,432 | |
| 1,232,289 | Institution | 1.71% | 78,410,549 | |
| 901,742 | Institution | 1.25% | 57,287,669 | |
| 757,102 | Institution | 1.05% | 42,851,973 | |
| 581,282 | Institution | 0.81% | 32,900,561 | |
| 440,477 | Institution | 0.61% | 28,027,552 | |
| 372,967 | Institution | 0.52% | 23,731,890 | |
| 258,119 | Institution | 0.36% | 16,398,300 | |
| 240,207 | Institution | 0.33% | 13,595,716 |
FAQ
Who Owns Kymera Therapeutics (KYMR)?
According to the latest TipRanks data, approximately 17.44% of the company's stock is held by institutional investors, 11.73% is held by insiders, and 26.25% is held by retail investors.
What percentage of Kymera Therapeutics (KYMR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.44% of Kymera Therapeutics (KYMR) stock is held by institutional investors.
What percentage of Kymera Therapeutics (KYMR) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.25% of Kymera Therapeutics (KYMR) stock is held by retail investors.
Who owns the most shares of Kymera Therapeutics (KYMR)?
Felix Baker owns the most shares of Kymera Therapeutics (KYMR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.